Skip to main content
John Mascola, MD, Infectious Disease, Bethesda, MD

John Robert Mascola MD

Infectious Disease•Bethesda, MD

HIV/AIDS Medicine, Microbiology

Physician

Join to view full profile

  • Rockville Pike# 8901Bethesda, MD 20889

  • Phone+1 301-295-4611

  • Fax+1 301-480-2788

Dr. Mascola is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Mascola's full profileAlready have an account?

Education & Training

  • Naval Medical Center (San Diego)
    Naval Medical Center (San Diego)Residency, Internal Medicine, 1987 - 1989
  • Naval Medical Center (San Diego)
    Naval Medical Center (San Diego)Internship, Internal Medicine, 1985 - 1986
  • Georgetown University School of Medicine
    Georgetown University School of MedicineClass of 1985

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1987 - 2022

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2002

Publications & Presentations

PubMed

Journal Articles

  • Evaluation of the mRNA-1273 Vaccine Against SARS-CoV-2 in Nonhuman Primates  
    John R Mascola, The New England Journal of Medicine
  • Monoclonal Antibodies for Prevention and Treatment of COVID-19  
    John R Mascola, Myron S Cohen, JAMA
  • Structure-Based Design of a Quadrivalent Fusion Glycoprotein Vaccine for Human Parainfluenza Virus Types 1–4  
    John Mascola, MD, Proceedings of the National Academy of Sciences

Authored Content

  • Epitope-Based Vaccine Design Yields Fusion Peptide-Directed Antibodies That Neutralize Diverse Strains of HIV-1June 2020

Press Mentions

  • NIAID Vaccine R&D Director Who Collaborated with Moderna on COVID-19 Vaccine to Retire
    NIAID Vaccine R&D Director Who Collaborated with Moderna on COVID-19 Vaccine to RetireFebruary 16th, 2022
  • Vaccine Makers Pursue Omicron-Targeted Shots That Health Officials Say Might Not Be Needed
    Vaccine Makers Pursue Omicron-Targeted Shots That Health Officials Say Might Not Be NeededJanuary 14th, 2022
  • Covid-19 Vaccine Makers Assess Omicron Response
    Covid-19 Vaccine Makers Assess Omicron ResponseNovember 29th, 2021

Grant Support

  • Isolation And Deep Sequencing Of Monoclonal Antiobodies Against HIVNational Institute Of Allergy And Infectious Diseases2011
  • Determination Of The Neutralization Specificity In Broadly Neutralizing HIV SERANational Institute Of Allergy And Infectious Diseases2010–2011
  • Preclinical Evaluation Of Neutralizing Antibodies Elicited By HIV-1 ImmunogensNational Institute Of Allergy And Infectious Diseases2009–2011
  • Non-Human Primate Immunogenicity Studies Of HIV-1 ImmunogensNational Institute Of Allergy And Infectious Diseases2009–2011
  • NON Human Primate Models Of SIV And HIV Immune ProtectionNational Institute Of Allergy And Infectious Diseases2009–2011

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. John Mascola, Dr. John Mascola, MD, Dr. J Mascola, Dr. John Robert Mascola